Skip to content

Clinical trials

Central Nervous System Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20181
20212
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed2
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AbbVie1
Beijing Tiantan Hospital1
Binhui Biopharmaceutical Co., Ltd.1
Huashan Hospital1
Ming Yang1
Rongjie Tao1
Suzhou Maximum Bio-tech Co., Ltd.1
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms10
Brain Neoplasms4
Glioma2
Medulloblastoma2
Neoplasms2
Carcinoma, Neuroendocrine1
Ependymoma1
Lymphoma1
Neoplasm Metastasis1
Neoplasms, Germ Cell and Embryonal1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.